Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planTo cover taxesOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 3 of the 13 calendar months from Oct 2025 to Oct 2026: Mar 2026, Apr 2026 and May 2026.
- Largest single sale: $4.1M (52,975 shares) of Kymera Therapeutics, Inc. on Mar 23, 2026. Filing
- Last sale before this period: May 23, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | May 22, 2023 | May 27, 2026 |
| Madrigal Pharmaceuticals, Inc. (MDGL) | Former Sr. VP, Pgm Mgmt and Clin Ops | Feb 5, 2007 | Mar 3, 2010 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- May 27, 2026, Kymera Therapeutics, Inc.: sold 4,279 shares for $349K, under a disclosed plan. 1 filing: 1
- May 26, 2026, Kymera Therapeutics, Inc.: sold 12,905 shares for $1.0M, under a disclosed plan. 1 filing: 1
- Apr 22, 2026, Kymera Therapeutics, Inc.: sold 300 shares for $27K, under a disclosed plan; 300 shares acquired by exercising options. 1 filing: 1
- Apr 15, 2026, Kymera Therapeutics, Inc.: sold 1,300 shares for $117K, under a disclosed plan; 1,300 shares acquired by exercising options. 1 filing: 1
- Apr 14, 2026, Kymera Therapeutics, Inc.: sold 5,251 shares for $473K, under a disclosed plan; 5,251 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.